Iridex Corp Stock Ownership - Who owns Iridex?

Insider buying vs selling

Have Iridex Corp insiders been buying or selling?
Patrick MercerCOO2022-10-3071$2.27
Patrick MercerCOO2022-09-3072$2.41
Patrick MercerCOO2022-08-3071$2.55
Patrick MercerCOO2022-07-3071$3.01
Patrick MercerCOO2022-07-042,016$2.47
David BrucePresident and CEO2022-07-044,640$2.47
David BrucePresident and CEO2022-07-015,379$2.47
Patrick MercerCOO2022-07-011,460$2.47
David BrucePresident and CEO2022-06-303,227$2.57
Patrick MercerCOO2022-06-3072$2.57

1 of 2

IRIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRIX insiders and whales buy or sell their stock.

IRIX Shareholders

What type of owners hold Iridex Corp stock?
Blueline Catalyst Fund Ix LP16.00%2,559,122$6.17MInsider
Blueline Capital Partners Ii LP15.69%2,508,100$6.04MInsider
Blueline Partners LLC 115.53%2,483,815$5.99MInsider
Blueline Partners LLC15.42%2,465,222$5.94MInsider
Scott Shuda10.57%1,689,315$4.07MInsider
Topcon America Corp10.12%1,618,122$3.90MInsider
Associates Paragon Associates Ii Joint Venture Paragon8.26%1,320,000$3.18MInsider
Acuta Capital Fund LP7.24%1,157,011$2.79MInsider
Blueline Capital Partners LP7.12%1,138,862$2.74MInsider
Paragon Associates Paragon Associates Ii Joint Venture5.00%799,385$1.93MInstitution

1 of 3

IRIX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRIX15.64%84.36%Net Selling
POCI0.00%100.00%Net Buying
SSKN9.89%90.11%Net Buying
LNSR54.42%18.66%Net BuyingNet Buying

Iridex Stock Ownership FAQ

Who owns Iridex?

Iridex (NASDAQ: IRIX) is owned by 22.07% institutional shareholders, 119.05% Iridex insiders, and 0.00% retail investors. Blueline Catalyst Fund Ix LP is the largest individual Iridex shareholder, owning 2.56M shares representing 16.00% of the company. Blueline Catalyst Fund Ix LP's Iridex shares are currently valued at $6.17M.

If you're new to stock investing, here's how to buy Iridex stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.